Experts in neurology discuss the use of oral therapies in the treatment of relapsing-remitting multiple sclerosis (MS). They discuss treatment selection based on long-term and real-world data and how recent and emerging therapies will change the management of patients with relapsing-remitting MS.
EP. 1: Disease-Modifying Therapies (DMTs) in Multiple Sclerosis (MS)March 21st 2023
Mark S. Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC, provides an overview of disease-modifying therapies for the treatment of multiple sclerosis.
EP. 3: Risk of MS Disease Progression and Complementary Diagnostic ToolsMarch 28th 2023
Experts in neurology assess the risk of disease progression in a patient with MS and identify various biomarkers and diagnostic tools used to detect this.
EP. 5: Efficacy and Safety of Oral Therapies in MSApril 4th 2023
Experts in neurology present long-term efficacy and safety data of oral DMTs in the treatment of MS and share their perspective on the real-world significance.
EP. 9: Emerging Therapies and Unmet Needs in MSApril 11th 2023
Drs Ahmed Zayed and Mark S. Freedman review emerging therapies in the pipeline and unmet needs in the multiple sclerosis treatment landscape, as well as take-home thoughts.